Galmed Pharmaceuticals (GLMD) Return on Sales (2016 - 2019)
Galmed Pharmaceuticals (GLMD) posted quarterly Return on Sales of 0.03% for Q2 2019, up 3.0% year-over-year from 0.02% in Q2 2018, and up 13.26% quarter-over-quarter from 0.02% in Q4 2018.
Galmed Pharmaceuticals (GLMD) Return on Sales (2016 - 2019) Analysis & Trends
Galmed Pharmaceuticals' Return on Sales history runs 4 years deep, the most recent figure standing at 0.03% for Q2 2019.
- In Q2 2019, Return on Sales rose 3.0% year-over-year to 0.03%; the TTM figure through Jun 2019 stood at 0.03% (down 3.0% YoY), while the FY2018 annual figure was 0.05%, down 4.0% from the prior year.
- Return on Sales for Q2 2019 stood at 0.03%, up from 0.02% in the prior quarter.
- The five-year high for Return on Sales was 0.19% in Q3 2016, with the low at 0.0% in Q2 2018.
- The 4-year median for Return on Sales is 0.1% (2017), against an average of 0.08%.
- The sharpest annual moves came in 2018 and 2019: Return on Sales decreased 12 bps in 2018, then grew 3 bps in 2019.
- Galmed Pharmaceuticals' Return on Sales stood at 0.18% in 2016, then dropped by 24 bps to 0.13% in 2017, then sank by 83 bps to 0.02% in 2018, then grew by 13 bps to 0.03% in 2019.
- Business Quant data shows GLMD's Return on Sales at 0.03% in Q2 2019, 0.02% in Q4 2018, and 0.01% in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 0.03% |
| Dec 31, 2018 | 0.02% |
| Sep 30, 2018 | 0.01% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 0.13% |
| Sep 30, 2017 | 0.10% |
| Jun 30, 2017 | 0.10% |
| Mar 31, 2017 | 0.12% |
| Dec 31, 2016 | 0.18% |
| Sep 30, 2016 | 0.19% |